Agenus (AGEN) Net Margin Growth (3y) (2013 - 2026)

Agenus (AGEN) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 41,437.00

Historic Data

Download Data
DateValue
Mar 31, 2026 41,437.00
Dec 31, 2025 -19,155.00
Sep 30, 2025 44,955.00
Jun 30, 2025 11,313.00
Mar 31, 2025 8,128.00
Dec 31, 2024 15,252.00
Sep 30, 2024 -33,514.00
Jun 30, 2024 55,071.00
Mar 31, 2024 23,731.00
Dec 31, 2023 6,515.00
Sep 30, 2023 8,919.00
Jun 30, 2023 -9,664.00
Mar 31, 2023 -261.00
Dec 31, 2022 24,772.00
Sep 30, 2022 -1,003.00
Jun 30, 2022 10,038.00
Mar 31, 2022 -20,959.00
Dec 31, 2021 41,748.00
Sep 30, 2021 32,972.00
Jun 30, 2021 -62,119.00